All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Abatacept as a novel agent for the treatment of steroid-refractory cGvHD: A phase II trial
The results of a phase II clinical trial of abatacept for steroid-refractory chronic graft-versus-host disease (cGvHD) were presented by Anita Koshy1 at the...
Findings from the prospective iMAGINE trial of ibrutinib in pediatric patients with chronic GvHD
Chronic graft-versus-host disease (cGvHD) is a significant cause of mortality and morbidity after allogeneic hematopoietic stem cell transplantation...
"The new GvHD Hub is an amazing resource for physicians and healthcare professionals in the field of GvHD. We have recently seen some great advances in this era, and the GvHD Hub is the place to go for the most up-to-date information."
Are you a healthcare professional? What is your speciality?
Please select or type your speciality
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.